The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

DODAB     dimethyl-dioctadecyl-azanium

Synonyms: Ddbas compound, AC1L1PRI, CTK8G9601, AR-1K2564, LS-173187, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Dimethyldioctadecylammonium


High impact information on Dimethyldioctadecylammonium


Chemical compound and disease context of Dimethyldioctadecylammonium


Biological context of Dimethyldioctadecylammonium

  • The kinetics of the observed alteration of the immune response by DDA and DXS were very similar [10].
  • The MP- and DDA-based systems induced antibody responses at comparable levels whereas the DDA-based systems induced more powerful cell-mediated immune responses [11].

Anatomical context of Dimethyldioctadecylammonium


Associations of Dimethyldioctadecylammonium with other chemical compounds


Gene context of Dimethyldioctadecylammonium


Analytical, diagnostic and therapeutic context of Dimethyldioctadecylammonium


  1. Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine. Leal, I.S., Smedegârd, B., Andersen, P., Appelberg, R. Infect. Immun. (1999) [Pubmed]
  2. Delayed-type hypersensitivity and acquired cellular resistance in mice immunized with killed Listeria monocytogenes and adjuvants. Van Der Meer, C., Hofhuis, F.M., Willers, J.M. Immunology (1979) [Pubmed]
  3. Dissociation between enhanced resistance and delayed hypersensitivity induced with subcellular preparations from Listeria monocytogenes and the adjuvant dimethyl-dioctadecyl-ammonium bromide. Antonissen, A.C., Lemmens, P.J., van den Bosch, J.F., van Boven, C.P. Antonie Van Leeuwenhoek (1986) [Pubmed]
  4. Lipophilic quaternary ammonium salt acts as a mucosal adjuvant when co-administered by the nasal route with vaccine antigens. Klinguer, C., Beck, A., De-Lys, P., Bussat, M.C., Blaecke, A., Derouet, F., Bonnefoy, J.Y., Nguyen, T.N., Corvaïa, N., Velin, D. Vaccine (2001) [Pubmed]
  5. Enhanced response to chemoimmunotherapy and immunoprophylaxis with the use of tumor-associated antigens with a lipophilic agent. Prager, M.D., Gordon, W.C. Cancer Res. (1978) [Pubmed]
  6. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype. Hanyecz, A., Berlo, S.E., Szántó, S., Broeren, C.P., Mikecz, K., Glant, T.T. Arthritis Rheum. (2004) [Pubmed]
  7. Surfactant-encapsulated clusters (SECs): (DODA)20(NH4)[H3Mo57V6(NO)6O183(H2O)18], a case study. Kurth, D.G., Lehmann, P., Volkmer, D., Cölfen, H., Koop, M.J., Müller, A., Du Chesne, A. Chemistry (Weinheim an der Bergstrasse, Germany) (2000) [Pubmed]
  8. Interleukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccine. Leal, I.S., Flórido, M., Andersen, P., Appelberg, R. Immunology (2001) [Pubmed]
  9. The effects of adjuvants on immune responses in cattle injected with a Brucella abortus soluble antigen. Dzata, G.K., Confer, A.W., Wyckoff, J.H. Vet. Microbiol. (1991) [Pubmed]
  10. Immunomodulating properties of two synthetic adjuvants: dependence upon type of antigen, dose, and time of administration. Hilgers, L.A., Snippe, H., Jansze, M., Willers, J.M. Cell. Immunol. (1984) [Pubmed]
  11. A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice. Vangala, A., Kirby, D., Rosenkrands, I., Agger, E.M., Andersen, P., Perrie, Y. J. Pharm. Pharmacol. (2006) [Pubmed]
  12. Ribonuclease-sensitive ribosomal vaccines. Gonggrijp, R., Antonissen, A.C., van den Bosch, J.F., van Boven, C.P. Antonie Van Leeuwenhoek (1984) [Pubmed]
  13. Combinations of two synthetic adjuvants: synergistic effects of a surfactant and a polyanion on the humoral immune response. Hilgers, L.A., Snippe, H., Jansze, M., Willers, J.M. Cell. Immunol. (1985) [Pubmed]
  14. Adjuvant effect of quaternary ammonium compounds in a murine model. Larsen, S.T., Hansen, R., Hammer, M., Tegner, U., Poulsen, O.M., Nielsen, G.D. Toxicol. Lett. (2004) [Pubmed]
  15. A synthetic luteinizing hormone releasing hormone vaccine II. Temporal aspects of titer development and formulation trials in BALB/c mice. Silversides, D.W., Allen, A.F., Misra, V., Murphy, B.D., Mapletoft, R.J. J. Reprod. Immunol. (1988) [Pubmed]
WikiGenes - Universities